CPA6 Gene Epilepsy Familial Temporal Lobe Type 5 NGS Genetic DNA Test
Understanding CPA6 Gene Epilepsy Testing
The CPA6 Gene Epilepsy Familial Temporal Lobe Type 5 NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics. This advanced test specifically targets mutations in the CPA6 (Carboxypeptidase A6) gene, which has been scientifically linked to familial temporal lobe epilepsy type 5. Temporal lobe epilepsy is one of the most common forms of focal epilepsy, and understanding its genetic basis is crucial for effective management and treatment planning.
What Does This Test Measure?
Our comprehensive NGS-based test analyzes the entire coding region of the CPA6 gene to identify:
- Pathogenic variants associated with familial temporal lobe epilepsy type 5
- Missense, nonsense, and frameshift mutations in the CPA6 gene
- Genetic markers that influence seizure susceptibility and treatment response
- Inheritance patterns for family risk assessment
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Recurrent temporal lobe seizures with unknown cause
- Family history of epilepsy, especially temporal lobe epilepsy
- Unexplained episodes of altered consciousness or awareness
- Automatisms (repetitive movements) during seizures
- Psychic symptoms such as déjà vu or jamais vu
- Emotional changes preceding or following seizures
- Medication-resistant epilepsy requiring genetic insights
Clinical Benefits of CPA6 Gene Testing
Undergoing CPA6 gene testing provides numerous clinical advantages:
- Precise Diagnosis: Confirms genetic basis of temporal lobe epilepsy
- Personalized Treatment: Guides medication selection based on genetic profile
- Family Planning: Provides inheritance risk information for future generations
- Early Intervention: Enables proactive management strategies
- Reduced Diagnostic Uncertainty: Eliminates years of uncertainty about seizure causes
Understanding Your Test Results
Our comprehensive genetic counseling ensures you fully understand your results:
- Positive Result: Indicates presence of CPA6 gene mutation; enables targeted treatment and family screening
- Negative Result: Suggests CPA6 gene is not the cause; may indicate need for additional genetic testing
- Variant of Uncertain Significance: Requires ongoing monitoring and potential family studies
- Carrier Status: Important for family planning and genetic counseling
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York City, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality genetic testing services nationwide.
Take Control of Your Neurological Health
Don’t let uncertainty about your epilepsy diagnosis affect your quality of life. Our CPA6 Gene Epilepsy Test provides the clarity needed for effective treatment planning and family risk assessment. With results available in 3-4 weeks and comprehensive genetic counseling included, you’ll receive the expert guidance necessary to understand your genetic profile.
Ready to begin your genetic testing journey? Contact our genetic specialists today at +1(267) 388-9828 to schedule your appointment or book your test online. Our team is available to answer your questions and guide you through the testing process with compassion and expertise.
